FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574864554> ?p ?o ?g. }

• W2574864554 endingPage "1682" @default.
• W2574864554 startingPage "1675" @default.
• W2574864554 abstract "Background Thrombomodulin, an anticoagulant that inhibits thrombin-induced growth factor promotion, also has an anti-inflammatory effect. Furthermore, thrombomodulin inhibits nuclear factor-kappa B activation, which plays a crucial role in cancer progression. We assessed the antitumor activity of recombinant thrombomodulin for pancreatic cancer. Methods A xenograft orthotopic model was established in mice by implantation of human pancreatic cancer cells. The animals were treated with intraperitoneal injection of recombinant thrombomodulin 5 times a week for 4 weeks. Nuclear factor-kappa B activation was evaluated by measuring nuclear localization of the p65. Efficacy of recombinant thrombomodulin on the signal transduction of nuclear factor-kappa B was measured in vitro under preconditioning with thrombin or epidermal growth factor. Results Tumor growth was suppressed by recombinant thrombomodulin (P < .05). Recombinant thrombomodulin inhibited the expression of IκB kinase β (P < .05) and pIκBα (P < .01), as well as the activation of nuclear factor-kappa B NF-κB (P < .001). Furthermore, recombinant thrombomodulin inhibited thrombin-induced protease activate receptor 1 and nuclear factor-kappa B activation in vitro (P < .05). The number of Ki67-positive cells was decreased by recombinant thrombomodulin (P < .01). Recombinant thrombomodulin also suppressed body weight loss associated with pancreatic cancer (P < .05). No obvious adverse effects were observed. Conclusion Recombinant thrombomodulin significantly suppressed tumor growth against human pancreatic cancer by blocking thrombin-induced nuclear factor-kappa B activation without adverse effects. Thrombomodulin, an anticoagulant that inhibits thrombin-induced growth factor promotion, also has an anti-inflammatory effect. Furthermore, thrombomodulin inhibits nuclear factor-kappa B activation, which plays a crucial role in cancer progression. We assessed the antitumor activity of recombinant thrombomodulin for pancreatic cancer. A xenograft orthotopic model was established in mice by implantation of human pancreatic cancer cells. The animals were treated with intraperitoneal injection of recombinant thrombomodulin 5 times a week for 4 weeks. Nuclear factor-kappa B activation was evaluated by measuring nuclear localization of the p65. Efficacy of recombinant thrombomodulin on the signal transduction of nuclear factor-kappa B was measured in vitro under preconditioning with thrombin or epidermal growth factor. Tumor growth was suppressed by recombinant thrombomodulin (P < .05). Recombinant thrombomodulin inhibited the expression of IκB kinase β (P < .05) and pIκBα (P < .01), as well as the activation of nuclear factor-kappa B NF-κB (P < .001). Furthermore, recombinant thrombomodulin inhibited thrombin-induced protease activate receptor 1 and nuclear factor-kappa B activation in vitro (P < .05). The number of Ki67-positive cells was decreased by recombinant thrombomodulin (P < .01). Recombinant thrombomodulin also suppressed body weight loss associated with pancreatic cancer (P < .05). No obvious adverse effects were observed. Recombinant thrombomodulin significantly suppressed tumor growth against human pancreatic cancer by blocking thrombin-induced nuclear factor-kappa B activation without adverse effects." @default.
• W2574864554 created "2017-01-26" @default.
• W2574864554 creator A5004568947 @default.
• W2574864554 creator A5014949040 @default.
• W2574864554 creator A5025740085 @default.
• W2574864554 creator A5034883605 @default.
• W2574864554 creator A5040335361 @default.
• W2574864554 creator A5042119154 @default.
• W2574864554 creator A5042955332 @default.
• W2574864554 creator A5048098520 @default.
• W2574864554 creator A5088937824 @default.
• W2574864554 date "2017-06-01" @default.
• W2574864554 modified "2023-09-22" @default.
• W2574864554 title "Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation" @default.
• W2574864554 cites W1566182873 @default.
• W2574864554 cites W1665357608 @default.
• W2574864554 cites W1935281437 @default.
• W2574864554 cites W1975273342 @default.
• W2574864554 cites W1994677927 @default.
• W2574864554 cites W2002869373 @default.
• W2574864554 cites W2010344521 @default.
• W2574864554 cites W2010917201 @default.
• W2574864554 cites W2016641969 @default.
• W2574864554 cites W2017456649 @default.
• W2574864554 cites W2018235565 @default.
• W2574864554 cites W2022279316 @default.
• W2574864554 cites W2029650614 @default.
• W2574864554 cites W2038148640 @default.
• W2574864554 cites W2043517527 @default.
• W2574864554 cites W2044321029 @default.
• W2574864554 cites W2061471952 @default.
• W2574864554 cites W2081107312 @default.
• W2574864554 cites W2081753893 @default.
• W2574864554 cites W2142423474 @default.
• W2574864554 cites W2160414927 @default.
• W2574864554 cites W2164714222 @default.
• W2574864554 cites W2315613727 @default.
• W2574864554 cites W3143952533 @default.
• W2574864554 doi "https://doi.org/10.1016/j.surg.2016.12.008" @default.
• W2574864554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28094003" @default.
• W2574864554 hasPublicationYear "2017" @default.
• W2574864554 type Work @default.
• W2574864554 sameAs 2574864554 @default.
• W2574864554 citedByCount "20" @default.
• W2574864554 countsByYear W25748645542017 @default.
• W2574864554 countsByYear W25748645542018 @default.
• W2574864554 countsByYear W25748645542019 @default.
• W2574864554 countsByYear W25748645542020 @default.
• W2574864554 countsByYear W25748645542021 @default.
• W2574864554 countsByYear W25748645542022 @default.
• W2574864554 countsByYear W25748645542023 @default.
• W2574864554 crossrefType "journal-article" @default.
• W2574864554 hasAuthorship W2574864554A5004568947 @default.
• W2574864554 hasAuthorship W2574864554A5014949040 @default.
• W2574864554 hasAuthorship W2574864554A5025740085 @default.
• W2574864554 hasAuthorship W2574864554A5034883605 @default.
• W2574864554 hasAuthorship W2574864554A5040335361 @default.
• W2574864554 hasAuthorship W2574864554A5042119154 @default.
• W2574864554 hasAuthorship W2574864554A5042955332 @default.
• W2574864554 hasAuthorship W2574864554A5048098520 @default.
• W2574864554 hasAuthorship W2574864554A5088937824 @default.
• W2574864554 hasConcept C104317684 @default.
• W2574864554 hasConcept C121608353 @default.
• W2574864554 hasConcept C126322002 @default.
• W2574864554 hasConcept C153911025 @default.
• W2574864554 hasConcept C201267052 @default.
• W2574864554 hasConcept C2777292125 @default.
• W2574864554 hasConcept C2780210213 @default.
• W2574864554 hasConcept C40767141 @default.
• W2574864554 hasConcept C502942594 @default.
• W2574864554 hasConcept C55493867 @default.
• W2574864554 hasConcept C71924100 @default.
• W2574864554 hasConcept C86803240 @default.
• W2574864554 hasConcept C89560881 @default.
• W2574864554 hasConceptScore W2574864554C104317684 @default.
• W2574864554 hasConceptScore W2574864554C121608353 @default.
• W2574864554 hasConceptScore W2574864554C126322002 @default.
• W2574864554 hasConceptScore W2574864554C153911025 @default.
• W2574864554 hasConceptScore W2574864554C201267052 @default.
• W2574864554 hasConceptScore W2574864554C2777292125 @default.
• W2574864554 hasConceptScore W2574864554C2780210213 @default.
• W2574864554 hasConceptScore W2574864554C40767141 @default.
• W2574864554 hasConceptScore W2574864554C502942594 @default.
• W2574864554 hasConceptScore W2574864554C55493867 @default.
• W2574864554 hasConceptScore W2574864554C71924100 @default.
• W2574864554 hasConceptScore W2574864554C86803240 @default.
• W2574864554 hasConceptScore W2574864554C89560881 @default.
• W2574864554 hasIssue "6" @default.
• W2574864554 hasLocation W25748645541 @default.
• W2574864554 hasLocation W25748645542 @default.
• W2574864554 hasOpenAccess W2574864554 @default.
• W2574864554 hasPrimaryLocation W25748645541 @default.
• W2574864554 hasRelatedWork W13521755 @default.
• W2574864554 hasRelatedWork W1531831633 @default.
• W2574864554 hasRelatedWork W1634992736 @default.
• W2574864554 hasRelatedWork W1977536763 @default.
• W2574864554 hasRelatedWork W1979576566 @default.
• W2574864554 hasRelatedWork W2076520482 @default.

• next